DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people

(2012) Yasushi Kirino et al.   ENDOCRINE JOURNAL

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

(2012) Pablo Aschner et al.   LANCET

Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin

(2012) Anja Schweizer et al.   Diabetes Therapy

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

(2011) D. Lamers et al.   DIABETES

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials

(2011) Matteo Monami et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus

(2011) Baptist Gallwitz   DRUGS

Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy

(2011) Baptist Gallwitz   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Changes of Dipeptidyl Peptidase IV (DPP-IV) in Obese Children with Weight Loss: Relationships to Peptide YY, Pancreatic Peptide, and Insulin Sensitivity

(2011) T. Reinehr et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

(2011) Yoshimasa Aso et al.   Translational Research

Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications

(2010) Michael A. Nauck   AMERICAN JOURNAL OF MEDICINE

Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats

(2010) Yasushi Kirino et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired β-Cell Function

(2010) Silke A. Herzberg-Schäfer et al.   PLoS One

Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme

(2009) E. Matteucci et al.   CURRENT MEDICINAL CHEMISTRY

Pathomechanisms of Type 2 Diabetes Genes

(2009) Harald Staiger et al.   ENDOCRINE REVIEWS

Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men

(2009) Richard D. Carr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals

(2008) Luigi Bouchard et al.   ACTA DIABETOLOGICA

β-cell failure in type 2 diabetes mellitus

(2008) Cristina Lencioni et al.   Current Diabetes Reports